{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:47:03Z","timestamp":1783698423583,"version":"3.55.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"publisher","award":["\u00a0"],"award-info":[{"award-number":["\u00a0"]}],"id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>As the global pandemic continues, new complications of COVID-19 in pediatric population have turned up, one of them being hemolytic uremic syndrome (HUS), a complement-mediated thrombotic microangiopathy (CM-TMA) characterized by triad of thrombocytopenia, microangiopathic hemolytic anemia and acute kidney injury (AKI). With both multisystem inflammatory syndrome in children (MIS-C) and HUS sharing complement dysregulation as one of the key factors, the aim of this case report is to highlight differences between these two conditions and also emphasize the importance of complement blockade as a treatment modality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case report<\/jats:title><jats:p>We describe a 21-month-old toddler who initially presented with fever and confirmed COVID-19. His condition quickly deteriorated and he developed oliguria, accompanied with diarrhea, vomiting and oral intake intolerance. HUS was suspected, supported with compelling laboratory findings, including decreased platelets count and C3 levels, elevated LDH, urea, serum creatinine and sC5b-9 and presence of schistocytes in peripheral blood, negative fecal Shiga toxin and normal ADAMTS13 metalloprotease activity. The patient was given C5 complement blocker Ravulizumab and started to display rapid improvement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although reports of HUS in the setting of COVID-19 continue to pour in, the questions of exact mechanism and similarities to MIS-C remain. Our case for the first time accentuates the use of complement blockade as a valuable treatment option in this scenario. We sincerely believe that reporting on HUS as a complication of COVID-19 in children will give rise to improved diagnosis and treatment, as well as better understanding of both of these intricating diseases.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2023.1092860","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T08:42:27Z","timestamp":1676450547000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Hemolytic uremic syndrome in the setting of COVID-19 successfully treated with complement inhibition therapy: An instructive case report of a previously healthy toddler and review of literature"],"prefix":"10.3389","volume":"11","author":[{"given":"Matija","family":"Mato\u0161evi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivanka","family":"Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0161a","family":"Davidovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Matkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Jakop\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Vukovi\u0107 Brinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Szil\u00e1gyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorottya","family":"Csuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Sinkovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Proh\u00e1szka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Vrlji\u010dak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovro","family":"Lamot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/annrheumdis-2020-217960","article-title":"Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking kawasaki disease (kawa-COVID-19): a multicentre cohort","volume":"79","author":"Pouletty","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40272-020-00435-x","article-title":"Multisystem inflammatory syndrome in children related to SARS-CoV-2","volume":"23","author":"Esposito","year":"2021","journal-title":"Pediatr Drugs"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 among children in China","volume":"145","author":"Dong","year":"2020","journal-title":"Pediatrics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ijcp.14494","article-title":"An overview of the COVID-19 complications in paediatric population: a pandemic dilemma","volume":"75","author":"Seth","year":"2021","journal-title":"Int J Clin Pract"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells10123580","article-title":"Pediatric atypical hemolytic uremic syndrome advances","volume":"10","author":"Raina","year":"2021","journal-title":"Cells"},{"key":"B6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1111\/jth.15050","article-title":"Is the COVID-19 thrombotic catastrophe complement-connected?","volume":"18","author":"Conway","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s00467-021-05370-8","article-title":"Thrombotic microangiopathy in children","author":"Palma","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1182\/bloodadvances.2020003471","article-title":"Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations","volume":"4","author":"Diorio","year":"2020","journal-title":"Blood Adv"},{"key":"B10","author":"Sinkovits","year":""},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40124-021-00259-4","article-title":"Treatment of MIS-C in children and adolescents","volume":"10","author":"Mahmoud","year":"2022","journal-title":"Curr Pediatr Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1681\/ASN.2006080811","article-title":"Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome","volume":"18","author":"Sellier-Leclerc","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1080\/0886022x.2022.2089167","article-title":"Clinical features of children with anti-CFH autoantibody-associated hemolytic uremic syndrome: a report of 8 cases","volume":"44","author":"Li","year":"2022","journal-title":"Ren Fail"},{"key":"B15","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1053\/j.ajkd.2004.02.010","article-title":"Non-enteropathic hemolytic uremic syndrome: causes and short-term course","volume":"43","author":"Constantinescu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.23876\/j.krcp.22.010","article-title":"A new pathological perspective on thrombotic microangiopathy","author":"Kim","year":"2022","journal-title":"Kidney Res Clin Pract"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2147\/cpaa.s17904","article-title":"Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome","volume":"3","author":"Ohanian","year":"2011","journal-title":"Clin Pharmacol Adv Appl"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1182\/blood-2007-08-106153","article-title":"Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation","volume":"111","author":"St\u00e5hl","year":"2008","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","article-title":"Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome","volume":"24","author":"Ariceta","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.kint.2021.02.026.","article-title":"Acute kidney injury in pediatric patients hospitalized with acute COVID-19 and multisystem inflammatory syndrome in children associated with COVID-19","volume":"100","author":"Basalely","year":"2021","journal-title":"Kidney Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-016-0420-6.","article-title":"Turkish pediatric atypical hemolytic uremic syndrome registry: initial analysis of 146 patients","volume":"18","author":"Besbas","year":"2017","journal-title":"BMC Nephrol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.680567","article-title":"Case report: adult post-COVID-19 multisystem inflammatory syndrome and thrombotic microangiopathy","volume":"12","author":"Boudhabhay","year":"2021","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jped.2021.08.006","article-title":"Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes","volume":"98","author":"Santos","year":"2021","journal-title":"J Pediatr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1053\/j.ajkd.2013.09.020","article-title":"Skin involvement in atypical hemolytic uremic syndrome","volume":"63","author":"Ardissino","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1093\/ndt\/gfq160","article-title":"Myocardial infarction is a complication of factor H-associated atypical HUS","volume":"25","author":"Sall\u00e9e","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.663187","article-title":"Complement overactivation and consumption predicts in-hospital mortality in SARS-CoV-2 infection","volume":"12","author":"Sinkovits","year":"2021","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1055\/s-0041-1740182","article-title":"Associations between the von willebrand factor-ADAMTS13 axis, complement activation, and COVID-19 severity and mortality","volume":"122","author":"Sinkovits","year":"2022","journal-title":"Thromb Haemost"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-016774","article-title":"Toddler with new onset diabetes and atypical hemolytic-uremic syndrome in the setting of COVID-19","volume":"147","author":"Alizadeh","year":"2021","journal-title":"Pediatrics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s40620-020-00858-2","article-title":"Eculizumab treatment for renal failure in a pediatric patient with COVID-19","volume":"33","author":"Mahajan","year":"2020","journal-title":"J Nephrol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"117955652110498","DOI":"10.1177\/11795565211049897","article-title":"Thrombotic microangiopathy in a severe pediatric case of COVID-19","volume":"15","author":"Dalk\u0131ran","year":"2021","journal-title":"Clin Med Insights Pediatr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"103400","DOI":"10.1016\/j.amsu.2022.103400","article-title":"Severe SARS-COV-2 infection in pediatric patient with atypical hemolytic uremic syndrome: a case report","volume":"75","author":"Hamza","year":"2022","journal-title":"Ann Med Surg"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-022-05457-w","article-title":"Pathology findings in pediatric patients with COVID-19 and kidney dysfunction","author":"Nomura","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-021-05390-4","article-title":"Anti-factor H antibody associated hemolytic uremic syndrome following SARS-CoV-2 infection","author":"Khandelwal","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-022-05566-6","article-title":"Atypical hemolytic uremic syndrome induced by SARS - CoV2 infection in infants with EXOSC3 mutation","author":"Van Quekelberghe","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.791429","article-title":"Complement mediated hemolytic anemias in the COVID-19 era: case series and review of the literature","volume":"12","author":"Fattizzo","year":"2021","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1016\/j.ekir.2021.07.004","article-title":"Atypical hemolytic and uremic syndrome triggered by infection with SARS-CoV2","volume":"6","author":"Kaufeld","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1093\/hmg\/ddg363","article-title":"Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease","volume":"12","author":"Caprioli","year":"2003","journal-title":"Hum Mol Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1093\/hmg\/ddp289","article-title":"The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity","volume":"18","author":"Tortajada","year":"2009","journal-title":"Hum Mol Genet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin Nephrol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-7185-2","article-title":"Moraxella catarrhalis \u2013 pathogen or commensal","volume":"697","author":"Aebi","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1093\/infdis\/165-Supplement_1-S38","article-title":"Nasopharyngeal colonization during the first year of life","volume":"165","author":"Aniansson","year":"1992","journal-title":"J Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/infdis\/169.6.1312","article-title":"Epidemiology of moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media","volume":"169","author":"Faden","year":"1994","journal-title":"J Infect Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"E2705","DOI":"10.1002\/lary.29564","article-title":"Microbiology of acute maxillary sinusitis in children","volume":"131","author":"Sawada","year":"2021","journal-title":"Laryngoscope"},{"key":"B46","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ijporl.2006.10.025","article-title":"Frequency of recovery of pathogens from the nasopharynx of children with acute maxillary sinusitis before and after the introduction of vaccination with the 7-valent pneumococcal vaccine","volume":"71","author":"Brook","year":"2007","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s10038-017-0356-0","article-title":"Genetic predisposition to infection in a case of atypical hemolytic uremic syndrome","volume":"63","author":"Van Den Heuvel","year":"2018","journal-title":"J Hum Genet"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/cid\/ciz023","article-title":"Clinical and virological characteristics of acute sinusitis in children","volume":"69","author":"Demuri","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/INF.0000000000002660","article-title":"Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children","volume":"39","author":"Zimmermann","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2021.760070","article-title":"Hematuria as an early sign of multisystem inflammatory syndrome in children: a case report of a boy with multiple comorbidities and review of literature","volume":"9","author":"Generali\u0107","year":"2021","journal-title":"Front Pediatr"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1111\/jth.14981","article-title":"COVID-19: a collision of complement, coagulation and inflammatory pathways","volume":"18","author":"Chauhan","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10102188","article-title":"Targeting the complement cascade in the pathophysiology of COVID-19 disease","volume":"10","author":"Ng","year":"2021","journal-title":"J Clin Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.796109","article-title":"Complement levels at admission reflecting progression to severe acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19): a multicenter prospective cohort study","volume":"9","author":"Henry","year":"2022","journal-title":"Front Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.120.047419","article-title":"Will complement inhibition be the new target in treating COVID-19-related systemic thrombosis?","volume":"141","author":"Campbell","year":"2020","journal-title":"Circulation"},{"key":"B55","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/itt.s284830","article-title":"Complement inhibition and COVID-19: the story so far","volume":"10","author":"Fodil","year":"2021","journal-title":"ImmunoTargets Ther"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.599417","article-title":"Treatment of rare inflammatory kidney diseases: drugs targeting the terminal complement pathway","volume":"11","author":"Ort","year":"2020","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27544-6","article-title":"Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction","volume":"12","author":"Diorio","year":"2021","journal-title":"Nat Commun"},{"key":"B58","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.cll.2019.07.006","article-title":"Analysis of the complement system in the clinical immunology laboratory","volume":"39","author":"Ling","year":"2019","journal-title":"Clin Lab Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1092860\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T08:42:31Z","timestamp":1676450551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1092860\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":58,"alternative-id":["10.3389\/fped.2023.1092860"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1092860","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]},"article-number":"1092860"}}